These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 25043692)
21. The effect of nicotine on the production of soluble fms-like tyrosine kinase-1 and soluble endoglin in human umbilical vein endothelial cells and trophoblasts. Kwon JY; Bai SW; Kwon YG; Kim SH; Kim CH; Kang MH; Linton JA; Park YW Acta Obstet Gynecol Scand; 2010; 89(4):565-571. PubMed ID: 20367431 [TBL] [Abstract][Full Text] [Related]
22. The effects of pravastatin on the normal human placenta: Lessons from ex-vivo models. Balan A; Szaingurten-Solodkin I; Swissa SS; Feinshtein V; Huleihel M; Holcberg G; Dukler D; Beharier O PLoS One; 2017; 12(2):e0172174. PubMed ID: 28199380 [TBL] [Abstract][Full Text] [Related]
23. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia]. Luo X; Liu DD; Qi HB; Yao ZW Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433 [TBL] [Abstract][Full Text] [Related]
24. Soluble endoglin contributes to the pathogenesis of preeclampsia. Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767 [TBL] [Abstract][Full Text] [Related]
25. Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia. Rahman RA; Murthi P; Singh H; Gurungsinghe S; Leaw B; Mockler JC; Lim R; Wallace EM Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260307 [TBL] [Abstract][Full Text] [Related]
26. Combining metformin and sulfasalazine additively reduces the secretion of antiangiogenic factors from the placenta: Implications for the treatment of preeclampsia. Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Nguyen TV; Tuohey L; Cluver C; Tong S; Kaitu'u-Lino TJ Placenta; 2020 Jun; 95():78-83. PubMed ID: 32452405 [TBL] [Abstract][Full Text] [Related]
27. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta. Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613 [TBL] [Abstract][Full Text] [Related]
28. Endoglin (CD105) expression is regulated by the liver X receptor alpha (NR1H3) in human trophoblast cell line JAR. Henry-Berger J; Mouzat K; Baron S; Bernabeu C; Marceau G; Saru JP; Sapin V; Lobaccaro JM; Caira F Biol Reprod; 2008 Jun; 78(6):968-75. PubMed ID: 18276933 [TBL] [Abstract][Full Text] [Related]
29. Glyceryl trinitrate inhibits hypoxia-induced release of soluble fms-like tyrosine kinase-1 and endoglin from placental tissues. Barsoum IB; Renaud SJ; Graham CH Am J Pathol; 2011 Jun; 178(6):2888-96. PubMed ID: 21641407 [TBL] [Abstract][Full Text] [Related]
30. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia. Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083 [TBL] [Abstract][Full Text] [Related]
31. MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production. Kaitu'u-Lino TJ; Tuohey L; Ye L; Palmer K; Skubisz M; Tong S Placenta; 2013 Feb; 34(2):168-73. PubMed ID: 23261267 [TBL] [Abstract][Full Text] [Related]
32. In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia. Gangooly S; Muttukrishna S; Jauniaux E PLoS One; 2014; 9(9):e107644. PubMed ID: 25251016 [TBL] [Abstract][Full Text] [Related]
33. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304 [TBL] [Abstract][Full Text] [Related]
34. Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera. Aoki Y; Yamamoto T; Fumihisa C; Nakamura A; Asanuma A; Suzuki M Am J Reprod Immunol; 2012 May; 67(5):413-20. PubMed ID: 22040284 [TBL] [Abstract][Full Text] [Related]
35. Review: the enigmatic role of endoglin in the placenta. Gregory AL; Xu G; Sotov V; Letarte M Placenta; 2014 Feb; 35 Suppl():S93-9. PubMed ID: 24252708 [TBL] [Abstract][Full Text] [Related]
38. Uteroplacental arterio-venous difference in soluble VEGFR-1 (sFlt-1), but not in soluble endoglin concentrations in preeclampsia. Paasche Roland MC; Lorentzen B; Godang K; Henriksen T Placenta; 2012 Mar; 33(3):224-6. PubMed ID: 22264588 [TBL] [Abstract][Full Text] [Related]
39. Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia. Nakashima A; Yamanaka-Tatematsu M; Fujita N; Koizumi K; Shima T; Yoshida T; Nikaido T; Okamoto A; Yoshimori T; Saito S Autophagy; 2013 Mar; 9(3):303-16. PubMed ID: 23321791 [TBL] [Abstract][Full Text] [Related]
40. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]